Dawnrays Pharmaceutical (Holdings) Management

How experienced are the management team and are they aligned to shareholders interests?

16.4yrs

Average management tenure

CEO

Weixian Wu (53 yo)

0.92yr

Tenure

Mr. Weixian Wu serves as Chief Executive Officer of Dawnrays Pharmaceutical (Holdings) Limited since February 16, 2022. He joined Nanjing PharmaRays Science and Technology Co., Ltd., a non-wholly owned sub...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Kei Ling Li	Co-Founder & Executive Chairman	20.25yrs	CN¥965.00k	7.16% CN¥ 143.9m
Yung Lai Hung	Co-Founder & Executive Director	28yrs	CN¥616.00k	0.13% CN¥ 2.5m
Weixian Wu	Chief Executive Officer	0.92yr	no data	no data
Yi Jun Wu	Chief Financial Officer	4.75yrs	no data	no data
Kit Ling Pang	Company Secretary	no data	no data	no data

16.4yrs

Average Tenure

58yo

Average Age

Experienced Management: 2348's management team is seasoned and experienced (16.4 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Kei Ling Li	Co-Founder & Executive Chairman	20.25yrs	CN¥965.00k	7.16% CN¥ 143.9m
Yung Lai Hung	Co-Founder & Executive Director	20.25yrs	CN¥616.00k	0.13% CN¥ 2.5m
Hao Xi Ede	Independent Non-Executive Director	7.58yrs	CN¥299.00k	no data
Hong Man Leung	Non-Executive Director	17.17yrs	CN¥249.00k	no data
Tung Sing Lo	Independent Non-Executive Director	12.25yrs	CN¥299.00k	no data
Ming Yee Lam	Independent Non-Executive Director	4.67yrs	CN¥299.00k	no data

14.7yrs

Average Tenure

58.5yo

Average Age

Experienced Board: 2348's board of directors are seasoned and experienced ( 14.7 years average tenure).